Atypical hemolytic uremic syndrome - PDFSEARCH.IO - Document Search Engine

Atypical hemolytic uremic syndrome
Results: 14

#	Item
1	Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris Add to Reading List Source URL: www.hemapherese.fr Language: English - Date: 2016-05-16 12:22:49 Anatomy Medicine Clinical medicine Blood disorders Acquired hemolytic anemia Nephrology Organ failure Hemolytic-uremic syndrome Syndromes Atypical hemolytic uremic syndrome Thrombotic microangiopathy Eculizumab
2	HUS ParisMode de compatibilité] Add to Reading List Source URL: www.hemapherese.fr Language: English - Date: 2016-05-16 12:27:10 Complement system Blood disorders Eculizumab Immunosuppressants Acquired hemolytic anemia Atypical hemolytic uremic syndrome Thrombotic microangiopathy TMA C5-convertase Nephrology Dialysis Factor H
3	Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report Add to Reading List Source URL: www.jmedicalcasereports.com Language: English Complement system Acquired hemolytic anemia Nephrology Hematopathology Hemolytic-uremic syndrome Syndromes Alexion Pharmaceuticals Factor H Complement factor I Anatomy Medicine Hematology
4	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2014-10-01 21:51:53 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
5	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
6	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-12 23:53:04 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
7	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
8	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
9	Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab - Continuing PBS authority application Add to Reading List Source URL: www.humanservices.gov.au Language: English - Date: 2015-03-05 22:46:33 Healthcare in Australia Eculizumab Immunosuppressants Hemolytic-uremic syndrome Pharmaceutical Benefits Scheme Medicare Dialysis Medical prescription Medicine Health Nephrology
10	Atypical Haemolytic Uraemic Syndrome (aHUS) – eculizumab Initial PBS authority application Add to Reading List Source URL: www.humanservices.gov.au Language: English - Date: 2015-03-09 19:12:48 Renal physiology Acquired hemolytic anemia Hemolytic-uremic syndrome Nephrology Syndromes Eculizumab Thrombocytopenia Renal function Creatinine Medicine Biology Health